Quantitative analysis of recreational psychoactive mushroom gummies in Portland, Oregon
Clinical Toxicology – February 20, 2025
Source: OpenAlex
Summary
Many recreational drug users are unknowingly consuming mislabeled psychoactive substances. Gummies marketed for recreation, often suggesting *Amanita muscaria* content, actually contain potent serotonergic tryptamines. Some products falsely claimed to be psilocybin-free. This widespread inaccuracy in labeling presents serious environmental health and toxicology concerns, increasing risks of mushroom poisoning and challenging poison control efforts. Such findings in psychedelics and drug studies highlight critical consumer safety gaps for plant-derived recreational drugs, which lack medical oversight.
Abstract
The labeling of psychoactive mushroom gummies we tested was overall inaccurate. Products suggesting Amanita muscaria content instead contained serotonergic tryptamines, including some which falsely claimed to be free of psilocybin.